. WhiteRH, RomanoPS, ZhouH, RodrigoJ, BargarW. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med1998; 158: 1525–31.
. CompPC, SpiroTE, FriedmanRJ, WhitsettTL, JohnsonGJ, GardinerGA, Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. J Bone Joint Surg Am2001; 83-A: 336–45.
4.
. WhiteRH, GettnerS, NewmanJM, TraunerKB, RomanoPS. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med2000; 343: 1758–64.
5.
. HirshJ. Evidence for the needs of out-of-hospital thrombosis prophylaxis: introduction. Chest1998; 114 (2 suppl evidence): 113S–4S.
6.
. LevineM, HirshJ, GentM, ArnoldA, WarrD, FalangaA, Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet1994; 343: 886–9.
7.
. RidkerPM, GoldhaberSZ, DanielsonE, RosenbergY, EbyCS, DeitcherSR, Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med2003; 348: 1425–34.
